DI
The startup develops real-time bioinformatic cybersecurity software that creates an alternate digital representation of trusted executable code to detect advanced malware before execution. This technology provides enterprises with enhanced visibility across all operating systems, ensuring endpoint protection against potential threats.
Updated 3 months ago
Funding
$5.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops real-time bioinformatic cybersecurity software that creates an alternate digital representation of trusted executable code to detect advanced malware before execution. This technology provides enterprises with enhanced visibility across all operating systems, ensuring endpoint protection against potential threats.